| SC 13D/A | 2024-04-01 | Fairmount Funds Management LLC | Dianthus Therapeutics, Inc. /DE/ | 2,950,487 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | 5AM Partners VII, LLC | Dianthus Therapeutics, Inc. /DE/ | 1,199,228 | 4.1% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Dianthus Therapeutics, Inc. /DE/ | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Third Rock Ventures IV, L.P. | Dianthus Therapeutics, Inc. /DE/ | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-09 | GV 2016, L.P. | Dianthus Therapeutics, Inc. /DE/ | 208,697 | 1.4% | EDGAR |
| SC 13G | 2024-02-02 | RA CAPITAL MANAGEMENT, L.P. | Dianthus Therapeutics, Inc. /DE/ | 2,995,023 | 10.0% | EDGAR |
| SC 13G | 2024-02-02 | BCLS Fund III Investments, LP | Dianthus Therapeutics, Inc. /DE/ | 2,992,028 | 10.0% | EDGAR |
| SC 13D | 2024-01-31 | Avidity Partners Management LP | Dianthus Therapeutics, Inc. /DE/ | 2,922,823 | 9.9% | EDGAR |
| SC 13D/A | 2024-01-24 | Fairmount Funds Management LLC | Dianthus Therapeutics, Inc. /DE/ | 2,947,317 | 9.9% | EDGAR |
| SC 13G | 2023-11-13 | FMR LLC | Dianthus Therapeutics, Inc. /DE/ | 2,218,212 | 15.0% | EDGAR |
| SC 13D | 2023-09-21 | Fairmount Funds Management LLC | Dianthus Therapeutics, Inc. /DE/ | 1,873,833 | 12.7% | EDGAR |
| SC 13D | 2023-09-21 | Viridian, LLC | Dianthus Therapeutics, Inc. /DE/ | 1,090,283 | 7.4% | EDGAR |
| SC 13G | 2023-09-21 | Venrock Healthcare Capital Partners III, L.P. | Dianthus Therapeutics, Inc. /DE/ | 927,706 | 6.3% | EDGAR |
| SC 13G | 2023-09-21 | 5AM Partners VII, LLC | Dianthus Therapeutics, Inc. /DE/ | 1,049,030 | 7.1% | EDGAR |
| SC 13D/A | 2023-09-15 | Atlas Venture Fund X, L.P. | Dianthus Therapeutics, Inc. /DE/ | 166,501 | 1.1% | EDGAR |
| SC 13G | 2023-05-15 | CITADEL ADVISORS LLC | Magenta Therapeutics, Inc. | - | 6.5% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | Magenta Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | GILDER GAGNON HOWE & CO LLC | Magenta Therapeutics, Inc. | 425,858 | 0.7% | EDGAR |
| SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | Magenta Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Magenta Therapeutics, Inc. | 3,000,000 | 5.0% | EDGAR |